BR100 Decreased By (-0.55%)
BR30 Decreased By (-1.2%)
KSE100 Decreased By (-0.52%)
KSE30 Decreased By (-0.48%)
AGHA 6.70 Increased By ▲ 0.02 (0.3%)
BECO 4.37 No Change ▼ 0.00 (0%)
BML 56.50 Decreased By ▼ -0.82 (-1.43%)
BOP 30.08 Decreased By ▼ -0.27 (-0.89%)
CNERGY 12.98 Decreased By ▼ -0.14 (-1.07%)
CSIL 5.32 Decreased By ▼ -0.09 (-1.66%)
FCCL 52.08 Decreased By ▼ -0.71 (-1.34%)
FFL 14.57 Decreased By ▼ -0.15 (-1.02%)
FNEL 1.18 Increased By ▲ 0.06 (5.36%)
KEL 6.12 Increased By ▲ 0.03 (0.49%)
KOSM 5.94 Increased By ▲ 0.21 (3.66%)
LOTCHEM 26.30 Decreased By ▼ -0.16 (-0.6%)
MLCF 91.44 Decreased By ▼ -1.72 (-1.85%)
NBP 163.70 Decreased By ▼ -0.96 (-0.58%)
NCPL 53.70 Decreased By ▼ -1.96 (-3.52%)
NPL 58.88 Decreased By ▼ -2.28 (-3.73%)
OGDC 314.50 Decreased By ▼ -2.23 (-0.7%)
PACE 9.84 Decreased By ▼ -0.03 (-0.3%)
PAEL 35.15 Decreased By ▼ -0.48 (-1.35%)
PIBTL 14.77 Increased By ▲ 0.09 (0.61%)
PPL 222.45 Decreased By ▼ -4.46 (-1.97%)
PRL 91.40 Decreased By ▼ -1.62 (-1.74%)
PTC 59.06 Decreased By ▼ -1.20 (-1.99%)
SSGC 23.22 Decreased By ▼ -0.59 (-2.48%)
TBL 8.75 No Change ▼ 0.00 (0%)
TELE 7.60 Decreased By ▼ -0.20 (-2.56%)
TPL 22.23 Decreased By ▼ -0.12 (-0.54%)
TPLP 12.69 Decreased By ▼ -0.28 (-2.16%)
TREET 21.80 Decreased By ▼ -0.36 (-1.62%)
TRG 56.59 Increased By ▲ 0.03 (0.05%)
By

KARACHI: The Drug Regulatory Authority of Pakistan (DRAP) has registered’ another locally produced ventilator, ‘Innovent’, in Pakistan, sources said Tuesday.

As per details, the Innovent ventilator, manufactured by Essence Industries Karachi, has successfully completed its clinical trials.

DRAP has officially registered the Innovent ventilator and issued a license to Essence Industries for its local production. In addition to meeting domestic demand, the ventilators will also be exported, contributing to the Pakistan’s economy.

The Innovent ventilator has a shelf life of five years and is specifically designed for use by elderly patients, DRAP sources added.

Talking to a private television channel, DRAP CEO Dr. Asim Rauf said the priority of promoting Made in Pakistan medicines and medical equipment.

“Pakistan’s pharmaceutical industry has entered a new era, and the export of locally produced ventilators will generate significant foreign exchange for the country. These live-saving machines will also serve as a symbol of Pakistan’s global recognition,” Dr. Asim Rauf stated. He further highlighted that the success of Made in Pakistan medical devices reflects the country’s growing technological capabilities and commitment to innovation.

Earlier in 2021, the Drug Regulatory Authority of Pakistan (DRAP) registered an indigenously-developed intensive care unit (ICU) ventilator named “i-LIVE”.

The life-support machine was developed by the Pakistan Atomic Energy Commission (PAEC).

Chief Executive Officer of the DRAP Dr. Asim Rauf said that the i-LIVE ventilator was registered for a five-year period under the DRAP Act 2012 after its thorough technical examination.

Comments

Comments are closed for this article.